BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37383232)

  • 1. Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.
    Li Y; Jia Y
    Front Immunol; 2023; 14():1195341. PubMed ID: 37383232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of 28 cases of anti
    Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
    Chen L; Su T; Liu Y
    BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination.
    Zlotnik Y; Gadoth A; Abu-Salameh I; Horev A; Novoa R; Ifergane G
    Front Immunol; 2021; 12():813487. PubMed ID: 35069602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
    Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis.
    Qiao T; Chen L; Jiang L; Wei H; Chen X; Li X; Chen Y; Xu Y
    Front Immunol; 2022; 13():986853. PubMed ID: 36211373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases.
    Wang S; Wang J; Li B; Hu N; Jin Y; Han S; Shang X
    Front Immunol; 2023; 14():1191823. PubMed ID: 37304289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
    Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognizing New-Onset Sleep Disorders in Autoimmune Encephalitis Often Prompt Earlier Diagnosis.
    Ralls F; Cutchen L; Grigg-Damberger MM
    J Clin Neurophysiol; 2022 Jul; 39(5):363-371. PubMed ID: 35239557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.
    Roberto KT; Espiritu AI; Fernandez MLL; Gutierrez JC
    Epilepsy Behav; 2020 Nov; 112():107462. PubMed ID: 32971385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-LGI1 Encephalitis With Co-occurring IgLON5 Antibodies: Clinical Features and Human Leukocyte Antigen Haplotypes.
    Schiff P; Muñiz-Castrillo S; Do LD; Fantini ML; Chanson E; Rogemond V; Honnorat J; Poncet-Megemont L
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37217310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report.
    Chung HY; Wickel J; Voss A; Ceanga M; Sell J; Witte OW; Geis C
    Medicine (Baltimore); 2019 May; 98(20):e15706. PubMed ID: 31096519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
    Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
    Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature.
    Kong DL
    World J Clin Cases; 2023 Jan; 11(2):408-416. PubMed ID: 36686352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
    Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
    Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilomotor Seizures in a Patient With LGI1 Encephalitis.
    Yang J; Sun Q; Yang G
    Front Neurol; 2020; 11():61. PubMed ID: 32153488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Leucine-rich glioma-inactivated Protein 1 antibody-associated encephalitis complicated by minimal change nephrotic syndrome: a case report.
    Zhang WJ; Gao N
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7556-7560. PubMed ID: 36314326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
    Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
    BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
    Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
    Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
    Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
    Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.